Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
ACR Open Rheumatology|November 29, 2019
Joint Estimation of Remission and Response for Methotrexate-Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta-AnalysisGyanendra Pokharel, Rob Deardon, Cheryl Barnabe, et al.
Clinical and Experimental Rheumatology|May 26, 2022
Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research InitiativeEmmanouil Rampakakis, Carter Thorne, Angela Cesta, et al.
Rheumatology (Oxford, England)|December 19, 2022
Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trialArnaud Constantin, Roberto Caporali, Christopher J Edwards, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 8, 2022
"From Where I Stand": using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ)Susan J Bartlett, Vivian P Bykerk, Orit Schieir, et al.
ACR Open Rheumatology|March 6, 2024
Having More Tender Than Swollen Joints is Associated With Worse Function and Work Impairment in Patients With Early Rheumatoid ArthritisCharis F Meng, Yvonne Lee, Orit Schieir, et al.
Annals of the Rheumatic Diseases|June 29, 2011
Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 yearsMahboob U Rahman, Jacqui Buchanan, Mittie K Doyle, et al.
ACR Open Rheumatology|November 29, 2019
Association of Arthritis Onset with Influenza: Analysis of the Canadian Early Inflammatory Arthritis CohortFatima Kudaeva, Mark Speechley, Neil Klar, et al.
Arthritis and Rheumatism|December 1, 2007
Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysisEdward Keystone, Roy Fleischmann, Paul Emery, et al.
Rheumatology (Oxford, England)|July 11, 2013
The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisDaniel E Furst, Jonathan Kay, Mary Chester Wasko, et al.
The Journal of Rheumatology|February 13, 2002
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritisUrsula Mason, Jose Aldrich, Ferdinand Breedveld, et al.
Pageof 10